Literature DB >> 29517030

Bringing down the cost of cancer treatment.

Elie Dolgin.   

Abstract

Entities:  

Mesh：

Year:  2018        PMID： 29517030     DOI： 10.1038/d41586-018-02483-3

Source DB:  PubMed          Journal:  Nature        ISSN： 0028-0836            Impact factor:   49.962


× No keyword cloud information.
  17 in total

1.  Pharmaceutical pricing conundrum: time to get rid of it?

Authors:  Livio Garattini; Anna Padula
Journal:  Eur J Health Econ       Date:  2018-11

2.  Economic Evaluation of Talimogene Laherparepvec Plus Ipilimumab Combination Therapy vs Ipilimumab Monotherapy in Patients With Advanced Unresectable Melanoma.

Authors:  Abdulaali R Almutairi; Nimer S Alkhatib; Mok Oh; Clara Curiel-Lewandrowski; Hani M Babiker; Lee D Cranmer; Ali McBride; Ivo Abraham
Journal:  JAMA Dermatol       Date:  2019-01-01       Impact factor: 10.282

3.  Cost-effectiveness and Budgetary Consequence Analysis of Durvalumab Consolidation Therapy vs No Consolidation Therapy After Chemoradiotherapy in Stage III Non-Small Cell Lung Cancer in the Context of the US Health Care System.

Authors:  Steven D Criss; Meghan J Mooradian; Deirdre F Sheehan; Leyre Zubiri; Melissa A Lumish; Justin F Gainor; Kerry L Reynolds; Chung Yin Kong
Journal:  JAMA Oncol       Date:  2019-03-01       Impact factor: 31.777

4.  Global costs, health benefits, and economic benefits of scaling up treatment and imaging modalities for survival of 11 cancers: a simulation-based analysis.

Authors:  Zachary J Ward; Andrew M Scott; Hedvig Hricak; Rifat Atun
Journal:  Lancet Oncol       Date:  2021-03       Impact factor: 41.316

Review 5.  Repurposing Infectious Diseases Vaccines Against Cancer.

Authors:  Liese Vandeborne; Pan Pantziarka; An M T Van Nuffel; Gauthier Bouche
Journal:  Front Oncol       Date:  2021-05-13       Impact factor: 6.244

Review 6.  The potential of CAR T therapy for relapsed or refractory pediatric and young adult B-cell ALL.

Authors:  Matthew H Forsberg; Amritava Das; Krishanu Saha; Christian M Capitini
Journal:  Ther Clin Risk Manag       Date:  2018-09-03       Impact factor: 2.423

7.  Mid-Infrared Imaging Is Able to Characterize and Separate Cancer Cell Lines.

Authors:  E Kontsek; A Pesti; M Björnstedt; T Üveges; E Szabó; T Garay; P Gordon; S Gergely; A Kiss
Journal:  Pathol Oncol Res       Date:  2020-06-16       Impact factor: 3.201

8.  The Role of Humanitarian Donations in Decreasing Preventable Mortality From Cancer in Low-Income Countries: Models to Improve Access to Life-Saving Medicines.

Authors:  Pat Garcia-Gonzalez; Gilberto Lopes; Erin Schwartz; Lawrence N Shulman
Journal:  J Glob Oncol       Date:  2018-07

Review 9.  Genetic Strategies for HIV Treatment and Prevention.

Authors:  Alexander Falkenhagen; Sadhna Joshi
Journal:  Mol Ther Nucleic Acids       Date:  2018-09-29       Impact factor: 8.886

10.  Cost-effectiveness of breast, lung, colon, prostate and cervical cancer outcomes in Brazil: a worldwide comparison.

Authors:  Rodrigo Pellegrini; Tomás Reinert; Carlos Henrique Barrios
Journal:  Ecancermedicalscience       Date:  2021-06-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.